drugset / Trial / NCT06490614

Dexmedetomidine and Nalbuphine as Analgesic Adjuvants to Bupivacaine in Superficial Cervical Block.

NCT06490614

Phase 4 Not yet recruiting 30 enrolled Kasr El Aini Hospital
RandomizedParallel-groupDouble-blindSupportive care

Summary

Anterior cervical discectomy and fusion (ACDF) nowadays is considered a common procedure.postoperative pain can hinder recovery and prolong hospital stay. The superficial cervical plexus block (SCPB) is a safe and simple technique that had been found to allow good pain relief in neck surgeries. The main drawback of SCPB was short duration, so adjuvants as dexmedetomidine and opioids has been used to increase analgesic duration and decrease the use of opioids. The current study will compare the efficacy of dexmedetomidine and nalbuphine as adjuvants to bupivacaine in SCPB in anterior cervical fusion surgeries.

Timeline

Start
2024-07
Primary completion
2024-10
Completion
2024-11

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Dexmedetomidine Other / unclassified 1 ug/kg Subcutaneous
Subject Nalbuphine Small molecule 10 mg Subcutaneous
Background Bupivacaine Other / unclassified 0.25 % Subcutaneous
Background Epinephrine Other / unclassified Subcutaneous

Indications

No indication recorded.